| [1] |
侯令密，李芳芳，杨宏伟，等. 全乳切除术后放射治疗对T1～2 N1 M0期三阴性乳腺癌预后的价值：一项基于监测、流行病学和最终结果数据库的研究[J/CD]. 中华乳腺病杂志(电子版), 2021, 15(6)：337-345.
|
| [2] |
周学鲁，黄海，邓艳庆. 乳腺癌孤立性对侧腹股沟淋巴结转移1例[EB/OL].[2023-05-01].
URL
|
| [3] |
Baba M, Tatsuta M, Miya A, et al. A case of breast cancer diagnosed by inguinal lymph node metastasis[J]. Breast Cancer, 2000, 7(2)：173-175.
|
| [4] |
Kilçiksiz S, Gökçe T, Kinay M. Isolated inguinal lymph node metastasis from breast carcinoma-case report and review of the literature[J]. J BUON, 2006, 11(2)：229-232.
|
| [5] |
Jebbin NJ, Adotey JM. Metastatic carcinoma of the breast with inguinal lymph node involvement: a report of two cases[J]. Niger J Clin Pract, 2008, 11(4)：383-385.
|
| [6] |
Goyal S, Puri T, Julka PK. Breast cancer with inguinal node recurrence[J]. J Egypt Natl Canc Inst, 2015, 27(1)：41-43.
|
| [7] |
Ganesh YP, Arulappan T, Sivaraja, et al. A rare case of isolated inguinal lymphnode metastasis from breast carcinoma - case report[J]. J Med Sci Clin Res, 2019, 7(1)：1167-1170.
|
| [8] |
Kimoto T, Kohno N, Okamoto A, et al. A case of contralateral inguinal lymph node metastases from breast cancer[J]. Surg Case Rep, 2021, 7(1)：99.
|
| [9] |
Das Majumdar SK, Muraleedharan A, Mahapatra BR, et al. Inguinal lymph node metastasis in treated breast cancer: an extremely rare presentation and review of literature[J]. BMJ Case Rep, 2022，15(6): e249152.
|
| [10] |
赵红梅，侯宽永，柳剑英. 乳腺癌淋巴系统腹股沟的特殊转移(附1例报告) [J]. 中国微创外科杂志，2004, 4(4)：2.
|
| [11] |
李倩，李俏，徐兵河，等. 17例乳腺癌腹股沟淋巴结转移患者的临床特征和预后分析[J]. 中华肿瘤杂志，2013, 35(3)：207-211.
|
| [12] |
Guerry RL, Pratt-Thomas HR. Carcinoma of supernumerary breast of vulva with bilateral mammary cancer[J]. Cancer, 1976, 38：2570-2574.
|
| [13] |
McMaster J, Dua A, Dowdy SC. Primary breast adenocarcinoma in ectopic breast tissue in the ulva[J]. Case Rep Obstet Gynecol, 2013, 2013：721 696.
|
| [14] |
周璐，徐静，徐琰. 循环肿瘤DNA检测在乳腺癌中的临床应用[J/CD]. 中华乳腺病杂志(电子版), 2022, 16(1)：47-50.
|
| [15] |
Liu B, Hu Z, Ran J, et al. The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: novel prognostic indexes based on ctDNA[J]. Breast, 2022，65：116-123.
|
| [16] |
Coombes RC, Page K, Salari R, et al. Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence[J]. Clin Cancer Res, 2019, 15；25(14)：4255-4263.
|
| [17] |
Sant M, Bernat-Peguera A, Felip E, et al. Role of ctDNA in breast cancer[J]. Cancers (Basel), 2022, 14(2)：310.
|
| [18] |
Hellman S, Weichselbaum RR. Oligometastases[J]. J Clin Oncol, 1995, 13(1): 8-10.
|
| [19] |
Katipally RR, Pitroda SP, Juloori A, et al. The oligometastatic spectrum in the era of improved detection and modern systemic therapy[J]. Nat Rev Clin Oncol, 2022, 19(9): 585-599.
|
| [20] |
欧丹，许赪，陈佳艺. Ⅳ期乳腺癌寡转移局部治疗进展[J]. 外科理论与实践，2018, 23(5)：469-471.
|
| [21] |
Choi SH, Kim JW, Choi J, et al. Locoregional treatment of the primary tumor in patients with de novo stage Ⅳ breast cancer: a radiation oncologist’s perspective[J]. Clin Brast Cancer, 2017, 18(2)：e167-e178.
|
| [22] |
Harris E, Barry M, Kell MR. Meta-analysis of determine if surgical resection of the primary tumor in the setting of stage Ⅳ breast cancer impacts on survival[J]. Ann Surg Oncol, 2013, 20(9)：2828-2834.
|
| [23] |
Lu S, Wu J, Fang Y, et al. The impact of surgical excision of the primary tumor in Ⅳ breast cancer on survival: a meta-analysis[J]. Oncotarget, 2018, 9(14)：11 816-11 823.
|
| [24] |
中国临床肿瘤学会指南工作委员会．中国临床肿瘤学会(CSCO)乳腺癌诊治指南[M]. 北京：人民卫生出版社，2021：76-98.
|
| [25] |
Wynn CS, Tang SC. Anti-Her-2 therapy in metastatic breast cancer: many choices and future directions[J]. Cancer Metastasis Rev, 2022, 41(1)：193-209.
|
| [26] |
李芷君，徐兵河. 中国乳腺癌临床研究进展[J/CD]. 中华乳腺病杂志(电子版), 2022, 16(1)：1-5.
|
| [27] |
王淑伟，殷进军，邵姜超，等. 放射治疗对乳腺癌寡转移局部控制的影响[J/CD]. 中华乳腺病杂志(电子版), 2023, 17(2)：72-79.
|